scholarly journals Surgical Treatment Strategies and Prognosis of Hepatocellular Carcinoma

10.5772/55890 ◽  
2013 ◽  
Author(s):  
Alessandro Uzzau ◽  
Maria Laura ◽  
Vittorio Cherchi ◽  
Serena Bertozzi ◽  
Claudio Avellini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Treatment ◽  
Treatment Strategies

Surgical treatment strategies for secondary peritonitis: Outcome in 278 patients

2001 ◽  
Vol 120 (5) ◽  
pp. A401-A401
Author(s):  
M BOERMEESTER ◽  
E BELT ◽  
B LAMME ◽  
M LUBBERS ◽  
J KESECIOGLU ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Treatment Strategies ◽  
Secondary Peritonitis

Current Treatment Strategies for Hepatocellular Carcinoma

2010 ◽  
Vol 6 (3) ◽  
pp. 199-206 ◽  
Author(s):  
Andrew Aronsohn ◽  
Smruti R. Mohanty
Keyword(s):  
Hepatocellular Carcinoma ◽  
Treatment Strategies ◽  
Current Treatment

6606 Innovation in surgical treatment of the hepatocellular carcinoma with vascular invasion

2009 ◽  
Vol 7 (2) ◽  
pp. 392
Author(s):  
O. Kotenko ◽  
A. Grinenko ◽  
A. Korshak
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Treatment ◽  
Vascular Invasion

scholarly journals Hepatocellular carcinoma treatment strategies – a case-based review

2015 ◽  
Vol 5 (2) ◽  
Author(s):  
Rute Alves ◽  
Manuel Teixeira Gomes ◽  
Carlos Sampaio Macedo ◽  
Helena P. Miranda ◽  
Filipe Nery
Keyword(s):  
Hepatocellular Carcinoma ◽  
Treatment Strategies ◽  
Case Based

scholarly journals Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment

2021 ◽  
Vol 13 (9) ◽  
pp. 967-978
Author(s):  
Francesca Carissimi ◽  
Matteo Nazzareno Barbaglia ◽  
Livia Salmi ◽  
Cristina Ciulli ◽  
Linda Roccamatisi ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Treatment ◽  
Tumor Cells ◽  
Circulating Tumor Cells

scholarly journals Transarterial Radioembolization Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium

2021 ◽  
pp. 1-4
Author(s):  
Kabalane Yammine ◽  
◽  
Sarah Khalife ◽  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Inferior Vena Cava ◽  
Right Atrium ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava ◽  
Treatment Strategies ◽  
Complete Response ◽  
Advanced Hepatocellular Carcinoma ◽  
The Right

Tumor thrombus infiltration of hepatocellular carcinoma (HCC) into the inferior vena cava and right atrium is rare and is associated with a poor prognosis due to the critical location of the tumor and the limited efficiency of the available treatment strategies. In this study, we report the case of a patient with advanced HCC and tumor thrombus in the inferior vena cava and right atrium who demonstrated complete response with mass retraction upon Yttrium-90 trans-arterial radioembolization (90Y- TARE) therapy. Throughout the 16 months follow-ups after the radioembolization, the patient was free of any complications, revealing no occurrence of radiation-induced pneumonitis or tumor recurrence.

scholarly journals Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma

2015 ◽  
Vol 7 (13) ◽  
pp. 1755 ◽  
Author(s):  
Laurence Lacaze
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Treatment ◽  
Hepatic Recurrence

scholarly journals Prediction of Post-hepatectomy Liver Failure in Patients With Hepatocellular Carcinoma Based on Radiomics Using Gd-EOB-DTPA-Enhanced MRI: The Liver Failure Model

2021 ◽  
Vol 11 ◽  
Author(s):  
Yuyan Chen ◽  
Zelong Liu ◽  
Yunxian Mo ◽  
Bin Li ◽  
Qian Zhou ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Failure ◽  
Treatment Strategies ◽  
Area Under The Curve ◽  
Training Cohort ◽  
Clinical Model ◽  
Preoperative Prediction ◽  
Medical Centers ◽  
Appropriate Treatment ◽  
Magnetic Resonance Imaging Mri

Objectives: Preoperative prediction of post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC) is significant for developing appropriate treatment strategies. We aimed to establish a radiomics-based clinical model for preoperative prediction of PHLF in HCC patients using gadolinium-ethoxybenzyl-diethylenetriamine (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).Methods: A total of 144 HCC patients from two medical centers were included, with 111 patients as the training cohort and 33 patients as the test cohort, respectively. Radiomics features and clinical variables were selected to construct a radiomics model and a clinical model, respectively. A combined logistic regression model, the liver failure (LF) model that incorporated the developed radiomics signature and clinical risk factors was then constructed. The performance of these models was evaluated and compared by plotting the receiver operating characteristic (ROC) curve and calculating the area under the curve (AUC) with 95% confidence interval (CI).Results: The radiomics model showed a higher AUC than the clinical model in the training cohort and the test cohort for predicting PHLF in HCC patients. Moreover, the LF model had the highest AUCs in both cohorts [0.956 (95% CI: 0.955–0.962) and 0.844 (95% CI: 0.833–0.886), respectively], compared with the radiomics model and the clinical model.Conclusions: We evaluated quantitative radiomics features from MRI images and presented an externally validated radiomics-based clinical model, the LF model for the prediction of PHLF in HCC patients, which could assist clinicians in making treatment strategies before surgery.

scholarly journals Recent advances in the surgical treatment of hepatocellular carcinoma

2014 ◽  
Vol 20 (39) ◽  
pp. 14381 ◽  
Author(s):  
Zenichi Morise
Keyword(s):  
Hepatocellular Carcinoma ◽  
Surgical Treatment ◽  
Recent Advances
Sign in / Sign up

Export Citation Format

Share Document